Contact Us | Visit imshealth.com | Français

Connected Solutions for You to Drive Healthcare Forward

REAL-WORLD EVIDENCE

Canadian Real-World Data from De-Identified EMR

 

Uncovering insights from real-world data to improve decision making and patient outcomes

As scientifically credible, anonymized patient-level data becomes more accessible around the globe, real-world evidence (RWE) is becoming the new currency in healthcare. Healthcare decisions can now be better informed in the real world, enabling physicians and payers to make decisions based on how the drug works with the patient in the doctor’s office and what impact the medication is having on the care of the patient.

DEPTH OF INSIGHT

Information is collected from electronic systems used in primary care practices to document patients’ clinical records, for reimbursement of performed services and for clinical audit. Patient demographics, clinical variables such as diagnoses and laboratory test results, therapeutic outcomes and treatments are tracked longitudinally, with history back to 2008 for retrospective studies. The underlying data has supported many client research and commercial projects and publications. For prospective studies additional insights such as patient surveys, QOL insights and physician commentary on prescribing decisions adds further unique value.

Click the image below for a larger view.

TECHNOLOGY-ENABLED ANALYTICS

IMS Health provides groundbreaking, built-for-purpose technology applications to enable healthcare RWE, and we ensure that quality management and patient privacy are never compromised.

  • Access the real-world data you need – Identify data sources to answer desired research questions; gain access to data set to analyze while ensuring patient privacy
  • Create data sets – Bring data across sources as needed and appropriate for analysis leveraging innovative technologies
  • Analyze the data using scientific rigor, clear governance and advanced analytic and processing capabilities

Click here to learn more about IMS Evidence 360 Cohort Builder and access to many data dimensions for ~865,000 patients in a single linked database.

EXPERTISE BEYOND DATA

To bring deeper insights into patient treatment and outcomes, and better understand the full patient pathway, IMS Brogan’s Health Access & Outcomes consultancy can assist with Burden of illness, Value of medicine, Unmet medical needs, Patient flows, Forecasting & planning, and Adherence / Disease progression evaluations.

Click on the Icon to
Download the Fact Sheet
Click on the Icon to
Download the Fact Sheet
Click on the Icon to
Download the Fact Sheet

Canada Real-World Evidence & HEOR Bibliography of Posters, Presentations and Abstracts

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

  • Cost-utility Analysis of Rituximab as a New Therapeutic Option for Rheumatoid Arthritis Patients in Canada (poster)

 

Privacy   |   Terms of Use    Copyright © 2016 IMS Health Incorporated. All rights reserved.